Deep Vein Thrombosis Clinical Trials | A Drug Pipeline Analysis Report 2023 | Key companies- Carbomimetics, Anthos Therapeutics, and others

United States, Nevada, Las Vegas, DelveInsight’s ‘Deep Vein Thrombosis Pipeline Insight 2023‘ report provides comprehensive global coverage of available, marketed, and pipeline Deep Vein Thrombosis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Deep Vein Thrombosis pipeline domain.

Key Takeaways from the Deep Vein Thrombosis Pipeline Report

• Over 5+ Deep Vein Thrombosis pipeline therapies are in various stages of development, and their anticipated acceptance in the Deep Vein Thrombosis market would significantly increase market revenue. 
• Leading Deep Vein Thrombosis companies developing novel drug candidates to improve the Deep Vein Thrombosis treatment landscape include Carbomimetics, Anthos Therapeutics, and others.
• Promising Deep Vein Thrombosis pipeline therapies in various stages of development include CM20201, Abelacimab, and others.

Deep Vein Thrombosis Overview

Deep vein thrombosis (DVT) is a medical condition that occurs when a blood clot forms in a deep vein. These clots usually develop in the lower leg, thigh, or pelvis, but they can also occur in the arm. The most serious complication of DVT happens when a part of the clot breaks off and travels through the bloodstream to the lungs, causing a blockage called pulmonary embolism (PE). If the clot is small, and with appropriate treatment, people can recover from PE. However, there could be some damage to the lungs. If the clot is large, it can stop blood from reaching the lungs and is fatal. Medication is used to prevent and treat DVT. Compression stockings (also called graduated compression stockings) are sometimes recommended to prevent DVT and relieve pain and swelling. These might need to be worn for 2 years or more after having DVT. In severe cases, the clot might need to be removed surgically.

Deep Vein Thrombosis Pipeline Analysis: Drug Profile

CM20201: Carbomimetics

Currently in the preclinical phase, CM20201, an efficient small glyco-drug with selective activity inhibition of Factor Xa, would be used in a first place for oncology related Deep Vein Thrombosis (DVT). Today, anticoagulants are the reference treatment but display major risk of uncontrollable life threatening bleeding.

Discover more about the emerging Deep Vein Thrombosis drugs @ Deep Vein Thrombosis Treatment Drugs

Deep Vein Thrombosis Key Companies

• Carbomimetics
• Anthos Therapeutics

Deep Vein Thrombosis Pipeline Therapies

• CM20201
• Abelacimab

Deep Vein Thrombosis Pipeline Therapeutics Assessment

• By development stage
• By product type
• By route of administration
• By molecule type
• By MOA type

Scope of the Deep Vein Thrombosis Pipeline Report 

• Coverage: Global
• Key Deep Vein Thrombosis Companies: Carbomimetics, Anthos Therapeutics, and others
• Key Deep Vein Thrombosis Pipeline Therapies: CM20201, Abelacimab, and others

Find out more about the Deep Vein Thrombosis treatment options in development @ Deep Vein Thrombosis Clinical Trials

Table of Contents

1. Introduction
2. Executive Summary
3. Overview
4. Pipeline Therapeutics
5. Late-Stage Products (Phase III)
6. Mid-Stage Products (Phase  II)
7. Early Stage Products (Phase  I/II)
8. Preclinical Stage Products
9. Discovery Stage Products
10. Therapeutic Assessment
11. Inactive Products
12. Collaborations Assessment- Licensing / Partnering / Funding
13. Unmet Needs
14. Market Drivers and Barriers
15. Appendix
16. About DelveInsight

Leading Reports by DelveInsight:

• Asthma Diagnostic Devices Market
• Chronic Obstructive Pulmonary Disease Treatment Devices Market
• Airway Management Devices Market
• Cough Assist Devices Market
• Pulse Oximeters Market
• Hemodialysis Catheter Devices Market
• Chronic Spontaneous Urticaria Market
• Gender Dysphoria Market
• Germany Healthcare Outlook
• Biopsy Devices Pipeline Insight
• Bacterial Conjunctivitis Market
• Infliximab Biosimilar Insight
• Eosinophilic Asthma Market
• Cushing Syndrome Market
• Functional Dyspepsia Market
• Peripherally Inserted Central Catheters (PICC) Devices Market

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. 

Contact Us

Kritika Rehani

info@delveinsight.com 

+1(919)321-6187